Researchers Identify Abnormal Plasma Proteins From Patients With Gout Using HPLC-MS/MS
Researchers detected differential proteins in the plasma of patients with gout, patients with gout with kidney damage, and individuals without gout.
Kidney Disease
Chronic Kidney Disease: What Your Patients Need to Know
Although chronic kidney disease (CKD) is among the more common kidney ailments, patients may not be well-versed in its symptoms or complications. What should patients know about CKD, and how should healthcare providers be educating them?
Update for SGLT2 Inhibitors: Temporary Discontinuation Prior to Surgery Recommended
The FDA has approved safety labeling changes for sodium glucose co-transporter-2 (SGLT2) inhibitors. These include canagliflozin, dapagliflozin, empagliflozin, and ertugliflozin.
Empagliflozin Fast-Tracked for Chronic Kidney Disease Treatment
The FDA has granted Fast Track designation for empagliflozin (Jardiance; Boehringer Ingelheim and Lilly) to reduce the risk of kidney disease progression and cardiovascular (CV) death in adults with chronic kidney disease.
Treat-to-Target Approach May Improve Renal Function in Patients With Gout and Chronic Kidney Disease
Researchers assessed changes in the estimated glomerular filtration rate among patients with gout with moderate renal impairment, using a treat-to-target approach for gout.
How to Recognize Chronic Kidney Disease in Primary Care
Chronic kidney disease (CKD) is a commonly diagnosed condition, affecting approximately 30 million adults in the United States.1 CKD refers to a diverse group of pathologies that result in kidney function decline for at least 3 months.2,3 Kidney disease etiologies are generally classified into 3 categories: prerenal, intrinsic renal, and postrenal. Prerenal disease is marked…
Preeclampsia History Increases Risk for End-Stage Kidney Disease
ESKD risk highest for women with preterm preeclampsia and/or preeclampsia in two pregnancies.
Gabapentin-Related CNS Side Effects in a Patient With ESRD
A recently published report describes the case of a 62-year-old patient who experienced rare but serious central nervous system (CNS) side effects following the initiation of gabapentin therapy.
Gabapentin-Related CNS Side Effects in a Patient With ESRD
A recently published report describes the case of a 62-year-old patient who experienced rare but serious central nervous system (CNS) side effects following the initiation of gabapentin therapy.
Procurement Biopsy of Deceased Donor Kidneys Poorly Reproduced
Also do not correlate well with reperfusion biopsies, not linked to transplant outcomes
- Loading...
Loading...
Next post in Transplantation
Loading... 
Loading...